Clinical trials: sponsored by University College, London
Neoplasm Metastasis, Pain
Virtual Reality for Advanced Cancer Pain
Background Pain is commonly experienced by people who are living with advanced (incurable) cancer. There is evidence to suggest virtual reality could help to relieve this pain: however, this evidence is poor quality with the…
- Conditions
- Neoplasm Metastasis, Pain, Palliative Care
- Trial name
- VRcan (NCT06534580)
- Testing
- Virtual Reality
- Where
- 4 sites in United Kingdom
- Volunteers
- 100 people
- Sponsor
- University College, London
Multiple Myeloma
Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma
The Cardamon trial is a phase 2 trial using the standard chemotherapy drugs cyclophosphamide and dexamethasone in combination with a new drug called Carfilzomib in patients with multiple myeloma.
- Trial name
- Cardamon (NCT02315716)
- Testing
- Autologous Stem Cell Transplant (ASCT), Consolidation with 4 cycles of CarCyDex
- Where
- 20 sites in United Kingdom
- Volunteers
- 281 people
- Sponsor
- University College, London
Cancer, Lung Cancer
The SUMMIT Study: A Cancer Screening Study
The SUMMIT Study will enrol 13,000 participants in order to investigate how cancer screening can be improved and delivered. The SUMMIT Study has two main aims: the first is to clinically validate a blood test for detecting…
- Trial name
- SUMMIT (NCT03934866)
- Testing
- Low Dose CT scan
- Where
- United Kingdom
- Volunteers
- 13,035 people, healthy volunteers welcome
- Sponsor
- University College, London
Cervical Cancer
Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer
Chemoradiation has been the standard treatment for advanced cervical cancer for a decade, but one third of women still die from a failure to control systemic disease.
- Trial name
- INTERLACE (NCT01566240)
- Testing
- Paclitaxel, Carboplatin, Radiotherapy
- Where
- 35 sites in Brazil, India and 3 more
- Volunteers
- 500 people
- Sponsor
- University College, London
Internalising Disorders, Anxiety
The Development and Piloting of 'Power Up': a Tool for Young People with Internalising/emotional Disorders to Make Shared Decisions in Child and Adolescent Mental Health Services (CAMHS)
Patients should be able to have a say in their care and treatment, but how this should work for children and young people with mental health difficulties is unknown.
- Conditions
- Internalising Disorders, Anxiety, Depression
- Trial name
- Power Up (NCT02552797)
- Testing
- Shared Decision Making tool
- Sponsor
- University College, London
Duchenne Muscular Dystrophy
The U.K. NorthStar Clinical Network
The goal of this natural history study is to capture the natural history of Duchenne Muscular Dystrophy (DMD) in children and adults in the United Kingdom. Children and adults with DMD will be invited to join.
- Trial name
- NS (NCT06711692)
- Where
- 26 sites in United Kingdom
- Volunteers
- 300 people
- Sponsor
- University College, London
Sleep Disordered Breathing
3D Printing of Positive Airway Pressure (PAP) Therapy Masks: a Single Site Pilot and Feasibility Study
This study is a single site pilot and feasibility study. We propose that 3D printing could be used to create customised masks for patients requiring Positive Airway Pressure (PAP) therapy.
- Trial name
- 3DPiPPIn (NCT04179123)
- Testing
- Customised PAP interfaces
- Where
- United Kingdom
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University College, London
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC
A single-arm phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status of 2 with recurrent or metastatic squamous cell carcinoma of the head and neck.
- Trial name
- POPPY (NCT03813836)
- Testing
- Pembrolizumab
- Where
- 12 sites in United Kingdom
- Volunteers
- 63 people
- Sponsor
- University College, London
Waldenstrom Macroglobulinemia
Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia
This study is for patients who have previously been treated for Waldenström's macroglobulinaemia (WM) and their disease has either not responded (known as refractory disease) or has returned (known as relapsed disease).
- Trial name
- PembroWM (NCT03630042)
- Testing
- Pembrolizumab, Rituximab
- Where
- 9 sites in United Kingdom
- Volunteers
- 17 people
- Sponsor
- University College, London
Depression, Anxiety
Mood Awareness Psychotherapy Support
The aim of this single arm feasibility trial is to examine an internet delivered, self-help program for depression and anxiety, based on psychodynamic therapy.
- Trial name
- MAPS (NCT06133582)
- Testing
- Internet Based Psychodynamic Psychotherapy
- Where
- United Kingdom
- Volunteers
- 45 people
- Sponsor
- University College, London
Lung Cancer
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
Low-dose CT (LDCT) screening for lung cancer (LCS) has been shown to reduce lung cancer specific mortality in multiple randomised controlled trials.
- Trial name
- ALPINE (NCT05902559)
- Where
- United Kingdom
- Volunteers
- 10,000 people
- Sponsor
- University College, London
HIV
Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection
People living with HIV (PLWH), even with an undetectable viral load (VL) on antiretroviral treatment (ART), develop health conditions, such as heart disease, diabetes, various cancers, and conditions that can affect the brain…
- Trial name
- PROACTIV (NCT06626555)
- Testing
- Letermovir
- Volunteers
- 36 people
- Sponsor
- University College, London
Prostate Cancer
Prostate Imaging Using MRI +/- Contrast Enhancement
This prospective clinical trial (PRostate Imaging using Mri +/- contrast Enhancement (PRIME)) aims to assess whether biparametric MRI (bpMRI) is non-inferior to multiparametric mpMRI (mpMRI) in the detection of clinically…
- Trial name
- PRIME (NCT04571840)
- Testing
- Multiparametric MRI +/- prostate biopsy, Biparametric MRI +/- prostate biopsy
- Where
- 31 sites in United States, Argentina and 13 more
- Volunteers
- 500 people
- Sponsor
- University College, London
Oropharyngeal Cancer
Lymphatic Mapping Of Oropharyngeal Cancer
A multi-centre validation study to evaluate whether a new imaging and surgical protocol would work as well as the current gold standard in identifying sentinel nodes in patients with oropharyngeal cancer.
- Trial name
- LOOC (NCT04498221)
- Testing
- Imaging procedure, Surgical procedure
- Where
- 2 sites in United Kingdom
- Volunteers
- 150 people
- Sponsor
- University College, London
Secondary Progressive Multiple Sclerosis (SPMS)
Multiple Sclerosis-Simvastatin Trial 2
Multiple Sclerosis (MS) is a progressive neurological disorder of the brain and spinal cord. It affects approximately 120,000 people in the United Kingdom and 2.5 million people globally.
- Trial name
- MS-STAT2 (NCT03387670)
- Testing
- Simvastatin
- Where
- 31 sites in United Kingdom
- Volunteers
- 964 people
- Sponsor
- University College, London
Brain Injury, Neurosurgery
Electrocorticographic Monitoring of Brain Retraction Injury (EMBRI)
A single centre IDEAL Stage 1 feasibility study using novel electrophysiological recording techniques in adult participants undergoing neurosurgery.
- Conditions
- Brain Injury, Neurosurgery, Brain Ischemia
- Trial name
- EMBRI (NCT06409806)
- Testing
- ECOG Array
- Where
- United Kingdom
- Volunteers
- 6 people
- Sponsor
- University College, London
DMD, BMD
Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies
Study aims to develop and to evaluate the neurophysiological and physiological response to a classical conditioning task.To better understand how Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) impacts…
- Trial name
- D-BRAIN (NCT06581887)
- Testing
- Classical conditioning task
- Where
- United Kingdom
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University College, London
Myelomeningocele, Brain Malformation
The Role of CSF in Chiari II Brain Malformation
Spina bifida, particularly its most severe form known as open spina bifida (myelomeningocele), is a significant congenital disorder that results in profound neurological impairments, including Chiari II malformation.
- Conditions
- Myelomeningocele, Brain Malformation, Chiari Malformation Type 2
- Trial name
- NCT06560788
- Testing
- collection of cerebrospinal fluid
- Volunteers
- 18 people
- Sponsor
- University College, London
Osteosarcoma
ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
There has been little improvement in outcome for patients with osteosarcoma (OS) over the last 20 years. There have been only a few clinical trials of new treatments and no major new therapies introduced recently.
- Trial name
- ICONIC (NCT04132895)
- Testing
- observational only, no interventions are prescribed in protocol.
- Where
- 22 sites in United Kingdom
- Volunteers
- 300 people
- Sponsor
- University College, London
Heart Failure With Reduced Ejection Fraction
VITAL - the Heart Failure With Reduced Ejection Fraction Sub-study
Heart failure affects over 1 million people in the United Kingdom. Approximately 50% have heart failure with reduced ejection fraction (HFrEF), a condition where the heart muscle does not contract properly.
- Trial name
- NCT06534151
- Testing
- CRT implantation
- Where
- United Kingdom
- Volunteers
- 30 people
- Sponsor
- University College, London